On 23 September 2026 Anthropic announced that its Claude AI agents had identified a previously undescribed enzyme system, array-associated reverse transcriptases (ART), found mainly in bacteriophages.
ART has three parts: a reverse transcriptase, a partner gene of unknown function, and a long array of evenly spaced DNA repeats resembling a CRISPR array.
About 950 Claude agents searched a DNA sequence database for about 21 hours using about 210 million tokens. They found 200,000+ reverse transcriptases and narrowed them to 20 top candidates.
The work is a preprint and not yet peer-reviewed; what ART does is still unknown. It is the first output of Anthropic's life-sciences group and wet lab, set up in the San Francisco Bay Area in spring 2026.
An enzyme that makes DNA from an RNA template, reversing the usual DNA-to-RNA flow. It was discovered in retroviruses in 1970 by Howard Temin and David Baltimore (Nobel 1975). Bacteria also use RTs in defence systems such as retrons and some CRISPR systems.
Simple Analogy: A photocopier that turns a printed page back into its original typed file.
| Feature | CRISPR-Cas | ART |
|---|---|---|
| Found in | Bacteria and archaea | Mainly bacteriophages |
| Repeat array | Yes; spacers are transcribed into guide RNAs | Yes; evenly spaced repeats expressed as short RNAs |
| Key enzyme | Cas nuclease (e.g., Cas9) | Reverse transcriptase plus a partner protein |
| Known function | Adaptive immunity; basis of genome editing | Not yet known |
AI safety and research company; maker of the Claude models; founded 2021
Genomics research institute; Feng Zhang's lab there pioneered CRISPR-Cas9 editing in mammalian cells
GS Paper III > Science and Technology > Biotechnology, AI
General Science > Biology > Viruses, enzymes
A virus that infects bacteria; among the most abundant biological entities on Earth.
Clustered Regularly Interspaced Short Palindromic Repeats; a bacterial immune system adapted for gene editing (Nobel Chemistry 2020: Charpentier and Doudna).
A research paper shared publicly before peer review.